Biomx Inc (PHGE) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Biomx Inc  (PHGE)


Biomx Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Biomx Inc's ROA in the second quarter of 2026?
Biomx Inc recorded a cumulative net loss of $-35 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -68.47%.

However, within the Healthcare sector 862 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4366, from total ROA ranking in the first quarter of 2026 at 5029.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -25.92 % -92.88 % 274.79 % -48.87 % -36.39 %
Y / Y Net Income Change - 149.9 % - - -
Net Income (TTM) in million -35 -25 -36 37 19
Return On Assets (TTM) -68.47 % -46.64 % -56.91 % 100.72 % 42.82 %
PHGE's Total Ranking # 4366 # 5029 # 43 # 101 # 359
Total Assets (TTM) in million 28 3 145 26 38
Seq. Total Assets Change 766.99 % -97.75 % 452.35 % -31.23 % -16.66 %
Seq. Net Income Change - - - 51.83 % -21.18 %



Return On Assets Company Ranking
Within: No.
Industry # 131
Sector # 863
Overall # 4459

Return On Assets Statistics
High Average Low
97.65 %
20.47 %
-218.34 %
(Sep 30 2025)   (Jun 30 2026)



  News about Biomx Inc Return on Assets ROA

BiomX Inc. on the Rise: Navigating Challenges and Driving Innovation in Biotech

Outline of Facts:1. Positive Phase 2 Trial Results: - BiomX announced positive topline results from its Phase 2 trial evaluating BX211 for the treatment of Diabetic Foot Osteomyelitis (DFO). - A conference call and webcast are scheduled to discuss the results, demonstrating proactive engagement with stakeholders.2. Return on Assets (ROA): - For Q4 2024, BiomX reported a Return on Assets (ROA) of 28.52%. - This figure, while positive, is below the company s average ROA of 44.33%, indicating an area of concern that stakeholders may scrutinize.




Financial Statements
Biomx Inc's Assets $ 28 million PHGE's Balance sheet
Biomx Inc's Income $ -4 million Quarterly PHGE's Income Statement
PHGE's Income by Division See PHGE's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 274.79 % -67.2 % 182.18 % -43.57 % 17.42 %
Total Assets in million 145 39 118 42 74
Y / Y Net Income Change - - - -21.83 % 20.41 %
Net Income in million -36 18 -26 28 36
Annual Return On Assets -25.04 % 45.97 % -22.26 % 67.95 % 49.05 %




More Return On Assets Ratios
PHGE's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PHGE's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PHGE's Competitors
Subscribers only: Roa for Biomx Inc's Suppliers
Subscribers only: Return On Assets for PHGE's Customers

You may also want to know
PHGE's Roi PHGE's Inventory Turnover Ratio PHGE's Growth Rates PHGE's Dividend Comparisons
PHGE's Profitability Ratios PHGE's Asset Turnover Ratio PHGE's Dividend Growth
PHGE's Roe PHGE's Valuation Ratios PHGE's Financial Strength Ratios PHGE's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA


Date modified: 2026-09-26T07:35:44+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.